PHC GROUPPHC Holdings Corporation

  • About Us
  • Group Companies
  • Products & Services
  • CSR
  • Investor Relations

About Us

Corporate Overview History Our Culture Leadership

Group Companies

Ascensia Epredia PHCbi Medicom LSI Medience

Products & Services

Cancer Pathology Biologic & Cell Preservation Diagnostic Testing Patient Record & Billing Software Diabetes Management Medical Device & Drug Delivery

CSR

CORPORATE INTEGRITY

  • Code of Conduct
  • Corporate Governance
  • Risk Management
  • Information Security
  • CSR Procurement
  • Developing Quality Products
  • Customer Satisfaction

PEOPLE INSIGHTS

  • Human Rights Policy
  • Promoting Diversity
  • Work Style Reform
  • Developing Human Resources
  • Creating a Safe & Healthy Workplace

ENVIRONMENTAL SUSTAINABILITY

  • Environmental Activities

SOCIAL RESPONSIBILITY

  • Solving Problems through Business
  • Regional Social Action Programs
  • COVID-19 Response

Investor Relations

INVESTOR RELATIONS

MANAGEMENT

  • Corporate Governance
  • IR Basic Policy

IR LIBRARY

  • Financial Results
  • Presentation Materials
  • IR Materials

STOCK INFORMATION

  • Stock Overview
  • General Meeting of Shareholders
  • Stock Quotations
IR News Financial Highlights IR Calendar Contact IR Disclaimer
NewsroomCareersContact
JP

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation

Other PHC Group Websites

  • PHC Corporation
  • Ascensia Diabetes Care
  • Epredia
  • LSI Medience Corporation
  • PT PHC Indonesia
  • PHC Corporation of North America
  • PHC Europe B.V.
  • PHC Medicom Corporation
  • PHC Corporation (Shanghai) Ltd.
  • SciMed(Asia)Pte Ltd
  • Amelieff Corporation
NewsroomCareersContactJP
Newsroom > 2021 > Company Operations During COVID-19 Imposed State of Emergency in Tokyo and Three Neighboring Prefectures

News


2021

AnnouncementJanuary 7

Company Operations During COVID-19 Imposed State of Emergency in Tokyo and Three Neighboring Prefectures

Our sincere condolences to victims of COVID-19, and hopes for the quick recovery of those who have been infected. We also offer sincere gratitude towards healthcare professionals who are working at the forefront to treat patients, and everyone who is helping to support the community infrastructure.

Responding to the COVID-19-related state of emergency in the metropolitan area including Tokyo, Kanagawa, Chiba, and Saitama declared by the Japanese Government on January 7, PHC Holdings Corporation (headquarters: Tokyo, Japan) will be closing company sites from January 8, prioritizing the safety of customers and employees. During the closure, PHC Group employees at the sites listed below will continue business operations by working from home, except in special cases where they perform essential duties that cannot be performed remotely, and will respond to customer inquiries by e-mail, phone calls, etc.

· Site closures

PHC Holdings Corporation Shimbashi Headquarters (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo)
PHC Corporation Shimbashi Headquarters (Address: 2-38-5 Nishi-Shimbashi, Minato-ku, Tokyo)
[Biomedical Business Unit]
 Tokyo Sales Office/Pharmacy System Sales Office/Delicart Sales Office (address as above)
 South Kanto Sales Office (Address: 1-16-32-106 Fujigaoka, Aoba-ku, Yokohama City, Kanagawa)
[Medical Information Systems Business Unit]
 East Japan Sales Office (address as above)
 Shibuya Business Transformation Center (Address: Tokyo Tatemono Shibuya Building 7F, 3-9-9 Shibuya, Shibuya-ku, Tokyo)
 Omiya Office (Address: Wellness Cube Omiya 3/4F, 1-853-8 Miyahara-cho, Kita-ku, Saitama City, Saitama)
[Anatomical Pathology Business Unit]
 Shinkoyasu Manufacturing Site (Address: 3-9 Moriya-cho, Kanagawa-ku, Yokohama City, Kanagawa)
 CS Repair Warehouse (Address: 3-22-16 Nishikojiya, Ota-ku, Tokyo)
Shonan Health Innovation Park Office (Address: Shonan Health Innovation Park B33F-4110, 34-10 2-26-1 Muraokahigashi, Fujisawa City, Kanagawa)

Details of additional upcoming measures will be announced respectively by each business unit in charge, where appropriate. Resuming of operations at these sites will be considered depending on government policies and the status of the COVID-19. We appreciate your understanding and apologize for any inconvenience or disruption that you may experience.

Other PHC Corporation sites in Japan will continue operations as usual at their offices, plants, etc. Details for other PHC Group companies will be announced separately and we ask you to refer to each company's website for further information.

The PHC Group has already implemented measures such as teleworking and videoconferencing to minimize the infection risk for customers and employees. The health and safety of our customers, patients, employees and their families are most important to us and we will continue to further strengthen measures to prevent internal and external spread of the infection, while working to ensure stable supply for customers and patients who rely on our products and services.

Media contact

Corporate Communications Group
PHC Holdings Corporation
+81-3-6778-5311

  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
Terms of UsePrivacy PolicyFacebookLinkedIn © PHC Holdings Corporation All rights reserved.